Study guide

9.3 Hemolytic Uremic Syndrome, Acute Kidney Injury & Structural Genital Anomalies

Pediatric Nursing Certification PED-BC

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Overview, Blueprint & Clinical Decision-Making

1.1 ANCC PED-BC Exam Facts, Scoring & Test Blueprint 1.2 The Pediatric Nursing Process & Clinical Judgment Model 1.3 Prioritization, Clinical Case Analysis & Practice Strategies

2 Chapter 2: Pediatric Growth, Development & Milestones

2.1 Infancy and Toddlerhood: Physical Growth & Motor Milestones 2.2 Preschool, School-Age & Adolescent Milestones 2.3 Developmental Theories: Erikson, Piaget, Kohlberg & Freud

3 Chapter 3: Pediatric Physical Assessment, Vital Signs & Diagnostic Screening

3.1 Pediatric Physical Examination & Age-Specific Vital Sign Norms 3.2 Pediatric Pain Assessment Scales & Developmental Screening 3.3 Pediatric Laboratory Values & Diagnostic Specimen Collection

4 Chapter 4: Pediatric Fluid, Electrolyte & Nutritional Management

4.1 Dehydration Severity, Oral Rehydration Therapy & IV Deficit Replacement 4.2 Pediatric Electrolyte Disturbances: Sodium, Potassium & Calcium Imbalances 4.3 Infant Nutrition, Formula Preparation, Failure to Thrive & Deficiencies

5 Chapter 5: Pediatric Respiratory Emergencies & Chronic Pulmonary Conditions

5.1 Upper Airway Obstruction: Croup, Epiglottitis & Foreign Body Aspiration 5.2 Lower Airway Infections: Bronchiolitis (RSV) & Pediatric Pneumonia 5.3 Chronic Pulmonary Disorders: Pediatric Asthma & Cystic Fibrosis Management

6 Chapter 6: Pediatric Congenital & Acquired Cardiovascular Disorders

6.1 Acyanotic Congenital Heart Defects: Left-to-Right Shunts & Obstructive Lesions 6.2 Cyanotic Defects & Complex Anomalies: Tetralogy of Fallot, TGA & Hypercyanotic Spells 6.3 Acquired Pediatric Heart Disease: Kawasaki Disease, Rheumatic Fever & Heart Failure

7 Chapter 7: Pediatric Neurological & Neuromuscular Disorders

7.1 Pediatric Seizure Disorders: Febrile Seizures, Epilepsy & Status Epilepticus 7.2 Central Nervous System Infections & Increased Intracranial Pressure 7.3 Structural Anomalies & Neuromuscular Disorders: Hydrocephalus, VP Shunts, Spina Bifida & Cerebral Palsy

8 Chapter 8: Pediatric Gastrointestinal & Hepatic Conditions

8.1 Acute Surgical Conditions: Pyloric Stenosis, Intussusception & Appendicitis 8.2 Congenital & Structural GI Anomalies: Cleft Lip/Palate, TEF & Hirschsprung Disease 8.3 Chronic GI & Malabsorption: Pediatric GERD, Celiac Disease & Inflammatory Bowel Disease

9 Chapter 9: Pediatric Renal & Genitourinary Conditions

9.1 Pediatric Urinary Tract Infections, Vesicoureteral Reflux & Enuresis 9.2 Glomerular Disorders: Minimal Change Nephrotic Syndrome & Acute Post-Streptococcal Glomerulonephritis 9.3 Hemolytic Uremic Syndrome, Acute Kidney Injury & Structural Genital Anomalies

10 Chapter 10: Pediatric Hematologic & Oncologic Conditions

10.1 Pediatric Anemias & Sickle Cell Disease Crises 10.2 Pediatric Bleeding Disorders: Hemophilia A/B & Immune Thrombocytopenia 10.3 Pediatric Leukemias, Solid Tumors & Oncologic Emergencies

11 Chapter 11: Pediatric Endocrine & Inborn Metabolic Disorders

11.1 Pediatric Type 1 Diabetes Mellitus & Diabetic Ketoacidosis Protocols 11.2 Pediatric Thyroid, Adrenal & Growth Hormone Disorders 11.3 Inborn Errors of Metabolism & Pubertal Disorders: PKU, Galactosemia & Precocious Puberty

12 Chapter 12: Pediatric Musculoskeletal, Integumentary & Infectious Disorders

12.1 Pediatric Orthopedics: Developmental Dysplasia of the Hip, Clubfoot, Scoliosis & Fractures 12.2 Pediatric Burns, Atopic Dermatitis & Dermatologic Conditions 12.3 Viral Exanthems, Communicable Diseases & Pediatric Sepsis Management

13 Chapter 13: Pediatric Pharmacology, Safe Dosage & Immunizations

13.1 Pediatric Pharmacokinetics, Weight-Based Calculations & Safe Dosing Limits 13.2 High-Alert Pediatric Medications, IV Infusion Safety & Vascular Access 13.3 CDC Childhood Immunization Schedules, Vaccine Safety & Catch-Up Guidelines

14 Chapter 14: Family-Centered Care, Psychosocial Health & Injury Prevention

14.1 Family-Centered Care Principles, Hospitalization Stress & Separation Anxiety 14.2 Developmentally Appropriate Procedural Preparation & Non-Pharmacological Comfort 14.3 Anticipatory Guidance, Car Seat Safety, Drowning & Poisoning Prevention

15 Chapter 15: Professional Role, Ethics, Legal Standards & Advocacy

15.1 Informed Consent, Minor Assent & Adolescent Confidentiality Rights 15.2 Mandatory Reporting: Identifying Child Abuse, Neglect & Human Trafficking 15.3 Evidence-Based Practice, Pediatric Quality Metrics & Interprofessional Collaboration

16 Chapter 16: Medication Reconciliation, Complementary Care & Interactions

16.1 Medication, Allergy & Treatment Reconciliation 16.2 Complementary Products & Treatment Interactions

17 Chapter 17: Individualized Assessment, Diversity & Psychosocial Safety

17.1 Culture, Resources, Religion & Individualized Care 17.2 Psychosocial Screening & Immediate Mental Health Safety

18 Chapter 18: Individualized Planning, Coordination & Family Teaching

18.1 Measurable Outcomes, Coordination & Delegation 18.2 Teach-Back, Return Demonstration & Learning Evaluation

19 Chapter 19: Patient Safety, Chronic Care & Outcome Evaluation

19.1 Withdrawal, Elopement, De-escalation & Risk Reduction 19.2 Chronic Care, Healthy Weight & Response Evaluation

9.3 Hemolytic Uremic Syndrome, Acute Kidney Injury & Structural Genital Anomalies

Key Takeaways Explain This Topic AI

Hemolytic Uremic Syndrome (HUS) is the leading cause of acquired pediatric acute kidney injury, defined by the classic triad of microangiopathic hemolytic anemia (schistocytes), severe thrombocytopenia, and acute renal failure following STEC O157:H7 enteritis.

Antibiotics and antimotility agents are strictly contraindicated in children with suspected or confirmed STEC diarrheal illness, as they induce massive bacterial Shiga toxin release and up to tenfold increase the risk of developing HUS.

Acute kidney injury (AKI) is categorized into prerenal (FENa <1%, responds to isotonic fluid boluses), intrinsic (FENa >2%, structural tubular injury from ischemia or nephrotoxins), and postrenal (obstructive, notably posterior urethral valves in infant males).

In male infants, cryptorchidism that persists beyond 6 months of age requires surgical orchiopexy by 6 to 12 months to preserve future spermatogenesis and facilitate testicular malignancy screening.

Neonatal circumcision is absolutely contraindicated in infants with hypospadias to preserve the prepuce for future surgical reconstruction, while testicular torsion is a surgical emergency demanding detorsion and bilateral orchiopexy within 6 hours to prevent testicular necrosis.

Last updated: October 2026

Hemolytic Uremic Syndrome, Acute Kidney Injury & Structural Genital Anomalies

Quick Overview: Pediatric renal emergencies and structural genitourinary conditions demand immediate clinical recognition and decisive nursing intervention. Hemolytic Uremic Syndrome (HUS) —the leading cause of acquired acute renal failure in previously healthy young children—stems from Shiga toxin-producing bacteria and carries strict pharmacological contraindications that every certified pediatric nurse must know. Concurrently, categorizing Acute Kidney Injury (AKI) across prerenal, intrinsic, and postrenal etiologies dictates fluid resuscitation versus fluid restriction. Finally, recognizing structural and surgical genital anomalies—from the foreskin-preserving mandates of hypospadias to the time-critical 6-hour surgical salvage window of testicular torsion —is essential for safeguarding long-term fertility and organ viability.

1. Hemolytic Uremic Syndrome (HUS)

Hemolytic Uremic Syndrome is the single most common cause of acquired acute kidney injury in previously healthy infants and toddlers, exhibiting a peak incidence between 6 months and 4 years of age .

Etiology & Transmission

Over 90% of pediatric HUS cases represent Typical (Diarrhea-Associated, D+) HUS , caused by infection with Shiga toxin-producing Escherichia coli (STEC) , most notably serotype O157:H7 , or less commonly Shigella dysenteriae type 1.

Primary Transmission Vectors: Ingestion of undercooked contaminated ground beef (e.g., hamburgers), unpasteurized cow or goat milk, unpasteurized fruit juices (apple cider), contaminated municipal or recreational water (swimming pools, lakes), contaminated raw produce (spinach, lettuce, sprouts), and direct contact with farm animals at petting zoos or agricultural fairs.

Pathophysiology & Microvascular Injury

Gastrointestinal Colonization: Ingested STEC bacteria adhere to the mucosal lining of the large intestine, elaborating Shiga toxins ( Stx-1 and Stx-2 ) that induce severe, crampy abdominal pain and watery diarrhea that turns grossly bloody (hemorrhagic colitis) within 1 to 3 days.

Toxemia & Endothelial Receptor Binding: Shiga toxins cross the damaged colonic epithelium into the systemic circulation, binding with extreme affinity to globotriaosylceramide (Gb3) glycolipid receptors. Gb3 receptors are densely expressed on endothelial cells lining the renal glomerular capillaries, afferent arterioles, and tubular epithelium.

Endothelial Lysis & Microthrombosis: Toxin internalization halts cellular protein synthesis, causing endothelial cell apoptosis and detachment from the basement membrane. The denuded, thrombogenic subendothelial surface triggers localized platelet activation, aggregation, and fibrin mesh deposition, creating widespread microvascular thrombi across the renal microcirculation.

The Classic Diagnostic Triad of HUS Classic Triad of Hemolytic Uremic Syndrome:

  • ├── 1. Microangiopathic Hemolytic Anemia (Schistocytes / helmet cells, high LDH, negative Coombs)
  • ├── 2. Severe Thrombocytopenia (Platelet consumption in microthrombi; normal PT/aPTT)
  • └── 3. Acute Renal Failure (Glomerular microthrombosis; oliguria, azotemia, elevated creatinine)

Microangiopathic Hemolytic Anemia (MAHA): As circulating red blood cells traverse narrowed, fibrin-occluded glomerular capillaries, they are mechanically sheared and fragmented. Peripheral blood smear displays characteristic schistocytes ("helmet cells", burr cells, fragmented RBCs) . Laboratory markers confirm Coombs-negative intravascular hemolysis: severe anemia (hemoglobin often 5 to 8 g/dL), marked reticulocytosis , elevated lactate dehydrogenase (LDH), unconjugated hyperbilirubinemia, and depleted haptoglobin.

Severe Thrombocytopenia: Platelets are rapidly consumed within the diffuse microvascular thrombi. Platelet counts drop precipitously, frequently below 20,000 to 50,000/mcL , manifesting as petechiae, purpura, and easy bruising. High-Yield Diagnostic Hallmark: The systemic coagulation cascade is NOT activated— Prothrombin Time (PT), International Normalized Ratio (INR), and activated Partial Thromboplastin Time (aPTT) remain entirely NORMAL , definitively distinguishing HUS from Disseminated Intravascular Coagulation (DIC)!

Acute Renal Failure (AKI): Microthrombotic occlusion of glomerular capillary loops drastically lowers the GFR. Patients develop oliguria or anuria, gross or microscopic hematuria, proteinuria, rapidly climbing BUN and serum creatinine, hyperkalemia, metabolic acidosis, and fluid retention with hypertension.

ABSOLUTE CLINICAL CONTRAINDICATIONS (Critical Board Focus)

Caution

1. ANTIBIOTICS ARE STRICTLY CONTRAINDICATED in suspected or confirmed STEC enteritis: Administering antibacterial agents (e.g., fluoroquinolones, trimethoprim-sulfamethoxazole, cephalosporins) induces rapid bacterial cell lysis and accelerates phage-mediated Shiga toxin transcription. This floods the circulation with a catastrophic surge of Shiga toxins, multiplying the risk of developing full-blown HUS by up to 10-fold!

2. ANTIMOTILITY AGENTS ARE STRICTLY CONTRAINDICATED: Drugs that inhibit intestinal peristalsis (e.g., loperamide, diphenoxylate-atropine) paralyze bowel transit, prolonging toxin contact with the colonic mucosa, maximizing systemic toxin absorption, and dramatically worsening renal and neurological outcomes.

Clinical Management & Transfusion Protocols

Early Aggressive Isotonic Hydration: Administering vigorous intravenous volume expansion (isotonic saline) during the initial diarrheal prodrome preserves renal cortical blood flow and significantly reduces the incidence of anuria and the need for renal replacement therapy.

Fluid Balance in Established HUS: Once oligoanuria is established, fluid intake must be strictly restricted to insensible losses plus urine output to prevent pulmonary edema and hypertensive crisis.

Packed Red Blood Cell (PRBC) Transfusions: Indicated for symptomatic anemia (hemoglobin <6 to 7 g/dL, extreme lethargy, tachycardia, or heart failure). PRBCs (5 to 10 mL/kg) are infused slowly over 3 to 4 hours.

Platelet Transfusion Restrictions: Routine platelet transfusions are CONTRAINDICATED! Infused platelets merely bind to exposed subendothelium, fueling new microvascular thrombi and aggravating renal glomerular necrosis. Platelets are strictly reserved for active, life-threatening hemorrhage or immediately prior to essential invasive surgical procedures (e.g., peritoneal dialysis catheter placement).

Renal Replacement Therapy (Dialysis): Approximately 50% of children with HUS require temporary dialysis. Peritoneal dialysis (PD) is preferred in infants and toddlers due to hemodynamic stability and avoidance of vascular access thrombosis; hemodialysis or continuous renal replacement therapy (CRRT) is utilized in unstable older children.

2. Pediatric Acute Kidney Injury (AKI)

Acute Kidney Injury is characterized by an abrupt (within 48 hours to 7 days) decline in renal filtration capacity, resulting in the accumulation of nitrogenous waste products (azotemia) and deregulation of extracellular volume and electrolytes.

Etiological Classification: Prerenal vs. Intrinsic vs. Postrenal

Classification Underlying Mechanisms & Causes Laboratory Biomarkers & Urine Indices Clinical Management Approach

Prerenal AKI (~50–70% of pediatric cases) Renal hypoperfusion without parenchymal tissue damage. Causes: Dehydration, severe gastroenteritis , hemorrhagic shock, sepsis, capillary leak from major burns, heart failure. FENa < 1% ; Urine Sodium < 20 mEq/L; Urine Specific Gravity > 1.020; BUN-to-Creatinine ratio > 20:1; hyaline casts. Promptly reversible! Responds rapidly to isotonic fluid bolus (20 mL/kg Normal Saline) with brisk urine output.

Intrinsic (Renal) AKI (~30–40% of cases) Direct structural parenchymal damage to glomeruli, tubules, or interstitium. Causes: Prolonged ischemia (ATN), nephrotoxic drugs (aminoglycosides, vancomycin, NSAIDs, amphotericin B, IV contrast), HUS, APSGN. FENa > 2% ; Urine Sodium > 40 mEq/L; Urine Specific Gravity ~1.010 (isosthenuria); muddy brown granular casts (ATN). Assess volume status before fluids. Oliguria with overload calls for restriction and renal consultation; concurrent hypovolemia can still require carefully monitored isotonic resuscitation. Do not use the intrinsic-AKI label alone to prohibit all fluids.

Postrenal AKI (~5–10% of cases) Bilateral mechanical obstruction to urinary outflow. Causes: Posterior Urethral Valves (PUV) in newborn males, bilateral UPJ obstruction, neurogenic bladder, bilateral nephrolithiasis. Urine indices variable; bilateral hydronephrosis on renal ultrasound; palpable distended bladder. Emergent relief of obstruction via urethral catheter decompression followed by surgical ablation or diversion.

Emergency Hyperkalemia Protocol in Pediatric AKI

Serum potassium elevation (>6.0 to 6.5 mEq/L) carries risk for fatal cardiac ventricular arrhythmias. The pediatric emergency protocol follows three sequential steps:

Membrane Stabilization (Immediate):

IV Calcium Gluconate 10% (0.5 to 1.0 mL/kg IV over 3 to 5 minutes) under continuous ECG monitoring.

Antagonizes potassium-induced myocardial membrane excitability within 1 to 3 minutes. Does NOT lower serum potassium levels!

Intracellular Potassium Shift (Temporary Redistribution):

IV Regular Insulin (0.1 units/kg) combined with IV Dextrose 25% (2 mL/kg or 0.5 g/kg) infused over 30 minutes (drives K+ into cells via Na+/K+ ATPase pump).

Nebulized Albuterol (high dose: 2.5 to 5.0 mg) activates beta-2 receptors to shift K+ intracellularly.

IV Sodium Bicarbonate (1 to 2 mEq/kg) indicated if accompanied by severe metabolic acidosis.

Potassium Elimination (Definitive Removal):

Loop Diuretics (IV Furosemide 1 to 2 mg/kg) if residual renal tubular function exists.

Gastrointestinal Binders: Sodium polystyrene sulfonate (Kayexalate) or Sodium zirconium cyclosilicate (Lokelma). Note: Avoid Kayexalate in neonates or patients with bowel ischemia due to intestinal necrosis risk.

Emergency Dialysis (Hemodialysis or Peritoneal Dialysis): The definitive therapy for hyperkalemia refractory to medical management.

  • 3. Structural & Acute Genital Conditions
  • Cryptorchidism (Undescended Testis)

Definition & Incidence: Failure of one or both testes to descend through the inguinal canal into the scrotal sac. Present in up to 30% of premature male infants and 3% to 4% of full-term males.

Natural History: Spontaneous testicular descent frequently occurs within the first 3 to 4 months of life, propelled by the normal postnatal surge in gonadotropins and testosterone. Spontaneous descent after 6 months of age is exceedingly rare.

Long-Term Clinical Risks of Non-Correction:

Impaired Spermatogenesis & Infertility: The higher core body temperature within the abdomen or inguinal canal (1.5°C to 2.0°C higher than the scrotum) induces progressive degeneration of testicular germ cells, leading to subfertility or azoospermia.

Testicular Malignancy (Seminoma): The risk of testicular germ cell cancer is 4 to 10 times higher than in the general population. While surgical repositioning does not eliminate malignancy risk, it places the gonad in an anatomical position where regular testicular self-examination and clinical palpation can detect early tumors.

Testicular Torsion & Inguinal Hernia: Higher incidence of spermatic cord twisting and associated patent processus vaginalis.

Management Guidelines: If the testis remains undescended at 6 months of age (corrected for gestational age), prompt referral to a pediatric urologist is indicated. Surgical Orchiopexy (mobilizing the spermatic cord and anchoring the testis into a dartos pouch within the scrotum) is recommended between 6 and 12 months of age (and definitely before 18 months).

Hypospadias

Anatomical Defect: Congenital anomaly where the urethral meatus is abnormally displaced along the ventral (undersurface) aspect of the penile shaft, rather than at the tip of the glans. Classification ranges from distal (glanular, subcoronal) to midshaft, penoscrotal, or perineal.

Associated Anomalies: Frequently accompanied by chordee (a fibrous ventral tethering band causing severe downward curvature of the penis during erection) and a hooded dorsal foreskin (redundant dorsal prepuce with complete absence of ventral foreskin).

CRITICAL NURSING INTERVENTION & ABSOLUTE CONTRAINDICATION:

ROUTINE NEONATAL CIRCUMCISION MUST BE STRICTLY WITHHELD!

The prepuce (foreskin) is essential vascularized tissue utilized by the pediatric urologist as a graft or flap for surgical urethroplasty and chordee repair.

The nurse must immediately document this contraindication, alert the obstetric and pediatric teams, and educate the parents.

Surgical Timing & Postoperative Care: Surgical repair is typically performed between 6 and 12 months of age (before toilet training and the developmental emergence of body image awareness). Postoperatively, the child has a transurethral stent or catheter draining into a double-diaper system (inner diaper collects stool, outer diaper collects urine from the stent to prevent fecal wound contamination). Avoid straddle toys (tricycles, rocking horses, walkers) for 2 to 4 weeks.

Epispadias & Bladder Exstrophy

Epispadias: A rare congenital defect where the urethral meatus opens on the dorsal (upper) aspect of the penis (or cleft clitoris in females). Highly associated with the exstrophy-epispadias complex .

Bladder Exstrophy: Severe midline abdominal wall defect where the anterior bladder wall fails to close, resulting in the eversion and exposure of the posterior bladder mucosal plate on the lower abdominal wall.

Neonatal Nursing Priority: Prevent desiccation and trauma to the exposed bladder mucosa. Immediately cover the bladder plate with a sterile, non-adherent, clear plastic wrap (plastic film) . Avoid gauze dressings (even saline-soaked), as dried cotton fibers adhere to and tear the delicate mucosal epithelium upon removal!

Testicular Torsion: A True Urological Emergency

Pathophysiology: Sudden twisting of the spermatic cord around its axis, obstructing venous outflow and rapidly leading to arterial thrombosis, severe testicular ischemia, and irreversible hemorrhagic necrosis.

Predisposing Anatomy: The "Bell-clapper deformity" , a congenital anomaly where the tunica vaginalis abnormally completely encircles the epididymis and testis, leaving them free-floating and prone to rotation within the scrotal cavity. Bimodal peak incidence: neonatal period and early adolescence ( 12 to 18 years ).

Clinical Presentation: Sudden, excruciating, acute unilateral scrotal pain, scrotal erythema, and swelling, often accompanied by lower abdominal pain, nausea, and vomiting.

Physical Exam Landmarks:

The affected testis is exquisitely tender, enlarged, horizontally oriented, and high-riding within the hemiscrotum due to cord shortening.

ABSENT CREMASTERIC REFLEX on the affected side (lightly stroking the ipsilateral inner thigh fails to cause normal elevation of the testicle; highly sensitive for torsion).

Diagnostic Protocol: Color Doppler scrotal ultrasound demonstrates absent or severely diminished intratesticular arterial blood flow. Crucial Rule: If clinical suspicion for torsion is high, surgical consultation must NEVER be delayed to obtain ultrasound imaging!

The Golden 6-Hour Salvage Window: Surgical exploration, detorsion, and bilateral orchiopexy must be performed within 6 hours of symptom onset (>90% salvage rate). Viability drops below 50% at 12 hours and plummets to <10% at 24 hours. Bilateral fixation is mandatory because the bell-clapper anatomical defect is bilateral in up to 80% of patients.